CFTR negatively regulates cyclooxygenase-2-PGE(2) positive feedback loop in inflammation

Area of Science:

• * Cell Biology
• * Molecular Biology
• * Immunology

Background:

• * Cystic fibrosis (CF) is an inherited disorder impacting epithelial cells, characterized by chronic airway inflammation.
• * Elevated inflammatory mediators like prostaglandins (PGs) are implicated in CF lung pathology, but the precise regulatory mechanisms are unclear.
• * The cystic fibrosis transmembrane conductance regulator (CFTR) is a crucial epithelial ion channel whose dysfunction underlies CF.

Purpose of the Study:

• * To investigate the role of CFTR in regulating cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) production in airway epithelia.
• * To elucidate the molecular mechanisms linking CFTR deficiency to inflammatory signaling pathways, including NF-κB and CREB.
• * To determine if CFTR acts as a negative regulator of PGE2-mediated inflammation.

Main Methods:

• * Comparison of COX-2 and PGE2 levels in CF bronchial epithelial cells (CFBE41o--) versus wild-type cells (16HBE14o--).
• * Analysis of NF-κB activity and COX-2 expression in CFTR knockout mice.
• * Assessment of PGE2 feedback loops involving PKA and CREB.
• * Evaluation of the effects of wild-type CFTR overexpression and CFTR protein expression under inflammatory stimuli (LPS, PGE2).

Main Results:

• * CF bronchial epithelial cells exhibited increased COX-2 expression, PGE2 overproduction, and elevated NF-κB activity compared to wild-type cells.
• * CFTR knockout mice showed higher levels of COX-2 and NF-κB activity, confirming a link between CFTR deficiency and hyper-inflammation.
• * A positive feedback loop involving PKA and CREB was identified for PGE2 production.
• * Overexpression of wild-type CFTR significantly reduced COX-2 expression in CF cells.
• * CFTR protein expression was upregulated by LPS and PGE2 challenge, suggesting a regulatory role.

Conclusions:

• * CFTR functions as a negative regulator of the PGE2-mediated inflammatory response in airway epithelia.
• * Defective CFTR leads to excessive NF-κB activation and subsequent overproduction of PGE2, contributing to inflammation in CF.
• * Targeting the CFTR pathway may offer therapeutic strategies for managing inflammation in cystic fibrosis.